Literature DB >> 6743484

Plasma levels and pharmacokinetics of sulphinpyrazone in renal impairment during chronic treatment: a case report.

J Godbillon, J P Schoeller, S Gauron, G Gosset, J P Fillastre.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6743484      PMCID: PMC1463582          DOI: 10.1111/j.1365-2125.1984.tb05033.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  Quantitative assay of sulphinpyrazone in plasma and urine by high-performance liquid chromatography.

Authors:  J B Lecaillon; C Souppart
Journal:  J Chromatogr       Date:  1976-06-23

2.  Plasma levels of sulfinpyrazone and of two of its metabolites after a single dose and during the steady state.

Authors:  B Rosenkranz; C Fischer; P Jakobsen; A Kirstein Pedersen; J C Frölich
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

3.  High-performance liquid chromatographic analysis of the sulfide metabolite of sulfinpyrazone in plasma.

Authors:  J Godbillon; S Gauron; G Gosset
Journal:  J Chromatogr       Date:  1982-02-12

4.  Induction of drug metabolizing enzymes by sulfinpyrazone.

Authors:  E Walter; C Staiger; J de Vries; R Zimmermann; E Weber
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

5.  Sulfinpyrazone kinetics after intravenous and oral administration.

Authors:  J B Lecaillon; C Souppart; J P Schoeller; G Humbert; P Massias
Journal:  Clin Pharmacol Ther       Date:  1979-11       Impact factor: 6.875

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.